Reception of New Biologically Active Substances on the Basis of Curcumin
Overview
The reception of new biologically active substances on the basis of Curcumin is a research work about the synthesis of unknown for scientific literature, improved property-having biologically active substances, based on the principle of synergism. Curcumin is a phenolic compound (composition 2%) of the plant-Curcuma Longa, spread in nature which was used as an antiseptic, anti-inflammatory, anti-inflammatory preparation in Ayurvedic medicine. Today it is known for its high activity in the treatment of oncological, cardiovascular, renal inflammatory diseases. Besides, it has antibacterial, antioxidant, insecticidal and antimicrobial activity, but its practical use is prevented by practical insolubility of Curcumin in water. That is why we aimed to get soluble curcumin in water and study its biological activity. For this purpose, we studied the possibility of glicolization of Curcumin and we got mono- and diglucoside of the curcumin. Based on Acetylaceston group in the molecule, we did the trial and got so called Schiff bases, new heterocyclic compounds and studied their both antibacterial activity with Shiff complexes and bio inorganic microelements. We have conducted the studies of all synthesized materials IR-(infrared), UV(ultraviolet)-HPLC (high pressure liquid Chromatography) MS-MS(mas-spectrometry-mas- spectrometry), Nuclear-Magnetic- Resonance (1H and 13C nuclears). The structure of all the accepted substances is clearly defined.
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2018
Development of an Innovative Drug-Delivery System for Improving the Bioavailability and Release of Curcumin Using Phosphatidylcholine and Silica-Based Nanoparticles
ISEF · 2026
Development of a Curcumin-Based Pentraxin Conjugate for Targeted Cancer Therapy
ISEF · 2026
Synthesis and Characterization of Novel pH-Responsive Dual-Layer Chitosan-Alginate Smart Nanogels for Curcumin Delivery With Relevance to Colorectal Cancer and Biological Validation in Drosophila melanogaster
ISEF · 2017
Alzheimer's Treatment: Solubilized Curcumin via Trans-Buccal Patch
ISEF · 2024
Designing Drugs by Artificial Intelligence: Novel Curcuminoids for the Treatment of Papillary Renal Cell Carcinoma Type II (PRCC2)
ISEF · 2016
Alginate-Based Gel Particle as a Novel Drug Delivery Vehicle for Curcumin
ISEF · 2014
Identification of Novel Broad-Spectrum Antimicrobial Compounds in Curcuma amada
ISEF · 2022
Year III: Optimizing the Bioavailability of Curcumin in Dugesia tigrina as a Model To Mitigate the Negative Effects of Radiotherapy
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair